Alphamab Oncology (HKG:9966)
Hong Kong · Delayed Price · Currency is HKD 7.70
-0.04 (-0.52%)
At close: Mar 27, 2026
Alphamab Oncology Employees
Alphamab Oncology had 484 employees as of June 30, 2025.
Employees
484
Change
n/a
Growth
n/a
Revenue / Employee
1.30M HKD
Profits / Employee
-261.97K HKD
Market Cap
7.46B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 484 | - | - |
| Dec 31, 2024 | 420 | -15 | -3.45% |
| Dec 31, 2023 | 435 | -37 | -7.84% |
| Dec 31, 2022 | 472 | 13 | 2.83% |
| Dec 31, 2021 | 459 | 125 | 37.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Shanghai Haohai Biological Technology | 2,156 |
| CK Life Sciences Int'l., (Holdings) | 1,920 |
| Lepu Biopharma | 546 |
| Ocumension Therapeutics | 505 |
| CARsgen Therapeutics Holdings | 362 |
| Abbisko Cayman | 226 |
| HBM Holdings | 210 |
| Beijing Luzhu Biotechnology | 205 |
Alphamab Oncology News
- 3 months ago - Alphamab Oncology's JSKN033 Cleared For Phase 2 Cervical Cancer Trial By Chinese Regulatory Agency - Nasdaq